BioVendor Group is a medium-sized healthcare and technology company specializing in the development, production, and distribution of innovative diagnostic products and technologies for laboratory diagnostics. The company positions itself as a technological leader with multiple brands and a strong focus on research and innovation. Their target audience includes physicians, patients, diagnostic laboratories, and the scientific community worldwide. The website reflects a professional and consistent brand image with clear navigation and relevant content about their key projects and services.
Technically, the website employs modern JavaScript libraries such as jQuery and Slick Carousel, uses Google Tag Manager for analytics, and is optimized for mobile devices with good SEO practices. The site is served over HTTPS with no visible security vulnerabilities in the content. Privacy and cookie policies are implemented with consent mechanisms, indicating a good level of privacy compliance. However, no explicit security policies or incident response contacts are published.
From a security perspective, the website demonstrates good practices such as HTTPS enforcement and cookie consent but lacks published security policies and incident response information. The WHOIS data is malformed and incomplete, which reduces trustworthiness from a domain registration perspective. Despite this, the professional website content and branding mitigate some concerns. No adult or questionable content is present, making the site safe for general audiences.
Overall, the website is well-designed, functional, and professional with moderate technical maturity and good privacy compliance. The main risk lies in the incomplete WHOIS data, which should be monitored. Strategic recommendations include publishing security and incident response policies, improving accessibility, and enhancing security headers to strengthen the security posture and trustworthiness.
Scanned ·
NIS2 and GDPR posture
GDPR outside view
53/ 100 · Medium
Checks completed
7of 7
NIS2 Art. 21(2)
a(a) Risk analysis and security policies: Not visible from outside
b(b) Incident handling: One indicator
c(c) Business continuity, backups and crisis management: Not visible from outside
d(d) Supply chain security: Not visible from outside
e(e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
f(f) Assessing the effectiveness of security measures: Not visible from outside
g(g) Cyber hygiene and security training: Not visible from outside
h(h) Cryptography and encryption: Partly checked
i(i) HR security, access control and asset management: One indicator
j(j) Multi-factor authentication and secured communications: Not visible from outside
Partly checked
One indicator
Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
6 findings rated critical or high. Fix these first.
Security headers
Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.
High
Missing Content-Security-Policy header
Controls resources the browser is allowed to load
What to do: Implement a Content-Security-Policy appropriate for your application
This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended
€25per month
TLS certificates and expiry
DNS records
SPF, DKIM and DMARC
Security headers
GDPR and NIS2 posture
Exposed services
Third-party trackers
Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.
Full report
€39.90one-time
The complete analysis as a PDF you can cite
Email delivery with an unlock code
Lifetime access to this report
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
SSL/TLS
72
Security headers
65
Email security
85
DNS health
80
Network security
20
GDPR outside view
53
Average
63
Not counted
NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
The certificate is not trusted by browsers
The website is not served over HTTPS
A database, remote desktop, file-sharing or Telnet service is reachable from the internet
The page loads a script from a compromised source
The domain registration has expired
SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Critical0–25
High26–49
Medium50–75
Low76–100
Breach exposure
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Dark web exposure
Add-on
Leaked records that mention biovendor.group, from OffSeq Breach.
No leaked records found
Breach holds no records for biovendor.group right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
BioVendor Group operates in the healthcare diagnostics sector with a diversified portfolio of brands and innovative projects such as CLIA, Microblot-Array, Next Generation Sequencing, miRNA, and LAMP. Their business model focuses on research-driven product development and global distribution. The company targets diagnostic laboratories, healthcare providers, and researchers. The presence in over 115 countries and a workforce of over 500 employees indicate a medium-sized enterprise with significant market reach. The company leverages partnerships and subsidiaries to cover various diagnostic fields, enhancing its competitive advantage. The website content and event participation suggest active engagement in industry education and innovation. No direct revenue or financial data is available, but the breadth of products and global presence imply stable growth and market positioning.
Security posture
The website enforces HTTPS and uses Google Tag Manager for analytics with privacy consent mechanisms, reflecting a baseline security posture. No security headers were detected in the provided data, and no explicit security or incident response policies are published, indicating room for improvement. The absence of exposed sensitive data and secure form handling are positive indicators. The malformed WHOIS data is a concern for domain trust but does not directly impact website security. Overall, the security maturity is moderate, with recommendations to implement security headers, publish security policies, and provide incident response contacts to enhance transparency and readiness.
Recommendations
Publish a dedicated security policy page outlining security practices and compliance.
Add incident response contact information or abuse reporting channels on the website.
Implement and configure security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
Improve website accessibility features to meet WCAG standards for broader user inclusivity.
Monitor and resolve WHOIS data issues to improve domain registration transparency and trust.
Site observations
Automated reading of the public site. Ratings are indicative.
Business
Company
BioVendor Group
Description
We develop, produce and distribute products and technologies for laboratory diagnostics. Our products are redefining the standards of cutting-edge diagnostics.
Key services
Diagnostic product development, Laboratory diagnostics solutions, Immunodiagnostics, Molecular diagnostics, Research and innovation
Content quality
good
Branding
consistent
Technology
Stack
jQuery, Slick Carousel, OpenTypeKit fonts, Google Tag Manager
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good
Security
Observed score
80/100
Good practices seen
HTTPS enforced
Consent management for cookies
No exposed sensitive data in HTML
Analytics and tracking
Services
Google Tag Manager
Tracking level
minimal
Privacy practices
good
Advertising
Transparency
basic
Site quality
Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high
Key observations
Website is fully accessible with rich content and navigation.
No direct contact emails or phone numbers found; only contact form available.
No explicit security or incident response policies published.
WHOIS data is incomplete and does not provide registrant details.
Website uses modern JavaScript libraries and Google Tag Manager for analytics.
Privacy and cookie policies are present with consent mechanisms.
No signs of adult or questionable content.
Multiple brands and subsidiaries are clearly presented.
Social media presence on LinkedIn and YouTube.
Technical notes
Notes
The website uses a modern front-end stack with jQuery and Slick Carousel for UI components and Google Tag Manager for analytics. Fonts are loaded via Adobe Typekit. The site is mobile optimized with responsive images and layout. No CMS or hosting provider information is evident from the HTML. Performance is moderate with asynchronous loading of analytics scripts. SEO is supported by proper meta tags and Open Graph data. Accessibility is basic but could be improved. No critical technical debt or vulnerabilities were detected in the HTML content. The site uses standard HTML5 and CSS with no deprecated elements.
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Reviews of this site
Share your experience with biovendor.group. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review biovendor.group.